Потвърден имейл адрес: path.ox.ac.uk
Reshaping human antibodies for therapy
L Riechmann, M Clark, H Waldmann, G Winter
Nature 332 (6162), 323-327, 1988
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
B Keymeulen, E Vandemeulebroucke, AG Ziegler, C Mathieu, L Kaufman, ...
New England journal of medicine 352 (25), 2598-2608, 2005
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
M Brüggemann, GT Williams, CI Bindon, MR Clark, MR Walker, R Jefferis, ...
The Journal of experimental medicine 166 (5), 1351-1361, 1987
Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
SP Cobbold, A Jayasuriya, A Nash, TD Prospero, H Waldmann
Nature 312 (5994), 548-551, 1984
" Infectious" transplantation tolerance
S Qin, SP Cobbold, H Pope, J Elliott, D Kioussis, J Davies, H Waldmann
Science 259 (5097), 974-977, 1993
CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
A Davies, DL Simmons, G Hale, RA Harrison, H Tighe, PJ Lachmann, ...
The Journal of experimental medicine 170 (3), 637-654, 1989
Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H
G Hale, MR Clark, R Marcus, G Winter, MJS Dyer, JM Phillips, ...
The Lancet 332 (8625), 1394-1399, 1988
Identification of regulatory T cells in tolerated allografts
L Graca, SP Cobbold, H Waldmann
The Journal of experimental medicine 195 (12), 1641-1646, 2002
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.
S Meri, BP Morgan, A Davies, RH Daniels, MG Olavesen, H Waldmann, ...
immunology 71 (1), 1, 1990
Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)
J Lundin, E Kimby, M Björkholm, PA Broliden, F Celsing, V Hjalmar, ...
Blood, The Journal of the American Society of Hematology 100 (3), 768-773, 2002
Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity
N Komatsu, ME Mariotti-Ferrandiz, Y Wang, B Malissen, H Waldmann, ...
Proceedings of the National Academy of Sciences 106 (6), 1903-1908, 2009
Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells
T Miyao, S Floess, R Setoguchi, H Luche, HJ Fehling, H Waldmann, ...
Immunity 36 (2), 262-275, 2012
Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
AJ Coles, MG Wing, P Molyneux, A Paolillo, CM Davie, G Hale, D Miller, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
PD Kottaridis, DW Milligan, R Chopra, RK Chakraverty, S Chakrabarti, ...
Blood, The Journal of the American Society of Hematology 96 (7), 2419-2425, 2000
The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy
AJ Coles, A Cox, E Le Page, J Jones, SA Trip, J Deans, S Seaman, ...
Journal of neurology 253, 98-108, 2006
The plasticity and stability of regulatory T cells
S Sakaguchi, DAA Vignali, AY Rudensky, RE Niec, H Waldmann
Nature Reviews Immunology 13 (6), 461-467, 2013
Limiting dilution analysis of cells in the immune system
I Lefkovits, H Waldmann
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
AJ Coles, M Wing, S Smith, F Coraddu, S Greer, C Taylor, A Weetman, ...
The Lancet 354 (9191), 1691-1695, 1999
Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients
R Calne, P Friend, S Moffatt, A Bradley, G Hale, J Firth, J Bradley, K Smith, ...
The Lancet 351 (9117), 1701-1702, 1998
Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants
SP Cobbold, R Castejon, E Adams, D Zelenika, L Graca, S Humm, ...
The Journal of Immunology 172 (10), 6003-6010, 2004
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20